Drawing for BOZEMAN HEALTH

USPTO serial 97895795

BOZEMAN HEALTH

Reviewed by CopyMark Law Group

Reg. 7357530Status 700Registered
Filing date
Status date
Registration date
Apr 9, 2024
Examiner
ALBANO, ASHLEY C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BOZEMAN HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
044HealthcareACTIVEFeb 6, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.SR): Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.

DateCodeEventWhat it means
Apr 9, 2024R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Apr 9, 2024NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 6, 2024AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Mar 5, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Mar 5, 2024IUAAUSE AMENDMENT ACCEPTED
Feb 7, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE
Feb 7, 2024IUAFUSE AMENDMENT FILED
Feb 6, 2024EAAUTEAS AMENDMENT OF USE RECEIVED
Feb 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2024DOCKASSIGNED TO EXAMINER
May 16, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
May 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance